# Agios Pharmaceuticals
 (stock symbol: AGIO) Logo in transparent PNG format

## Agios Pharmaceuticals
 Logo large

### Agios Pharmaceuticals
 Logo large Download PNG (46.24 KB)

![Agios Pharmaceuticals
 Logo large Download PNG (46.24 KB)](/img/orig/AGIO_BIG-9d39f12a.png)

## Agios Pharmaceuticals
 Logo icon format

### Agios Pharmaceuticals
 Logo icon format Download PNG (6.9 KB)

![Agios Pharmaceuticals
 Logo icon format Download PNG (6.9 KB)](/img/orig/AGIO-261e6670.png)

## About Agios Pharmaceuticals


Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

1. Website domain: agios.com
2. Employees: 390
3. Marketcap: $1.26 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
